377 related articles for article (PubMed ID: 15671302)
1. Effect of benzalkonium chloride on transscleral drug delivery.
Okabe K; Kimura H; Okabe J; Kato A; Shimizu H; Ueda T; Shimada S; Ogura Y
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):703-8. PubMed ID: 15671302
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate.
Okabe J; Kimura H; Kunou N; Okabe K; Kato A; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):740-4. PubMed ID: 12556407
[TBL] [Abstract][Full Text] [Related]
3. Ocular tissue distribution of betamethasone after anterior-episcleral, posterior-episcleral, and anterior-intrascleral placement of nonbiodegradable implants.
Okabe K; Kimura H; Okabe J; Ogura Y
Retina; 2007; 27(6):770-7. PubMed ID: 17621189
[TBL] [Abstract][Full Text] [Related]
4. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
[TBL] [Abstract][Full Text] [Related]
5. Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device.
Okabe K; Kimura H; Okabe J; Kato A; Kunou N; Ogura Y
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2702-7. PubMed ID: 12766076
[TBL] [Abstract][Full Text] [Related]
6. In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits.
Berezovsky DE; Patel SR; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7038-45. PubMed ID: 21791594
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes.
Lee SJ; Kim ES; Geroski DH; McCarey BE; Edelhauser HF
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4506-14. PubMed ID: 18503001
[TBL] [Abstract][Full Text] [Related]
8. Transscleral delivery of bioactive protein to the choroid and retina.
Ambati J; Gragoudas ES; Miller JW; You TT; Miyamoto K; Delori FC; Adamis AP
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1186-91. PubMed ID: 10752959
[TBL] [Abstract][Full Text] [Related]
9. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable scleral implant for controlled intraocular delivery of betamethasone phosphate.
Kunou N; Ogura Y; Honda Y; Hyon SH; Ikada Y
J Biomed Mater Res; 2000 Sep; 51(4):635-41. PubMed ID: 10880111
[TBL] [Abstract][Full Text] [Related]
11. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
Li J; Lan B; Li X; Sun S; Lu P; Cheng L
J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
[TBL] [Abstract][Full Text] [Related]
12. A novel design of one-side coated biodegradable intrascleral implant for the sustained release of triamcinolone acetonide.
Kim YM; Lim JO; Kim HK; Kim SY; Shin JP
Eur J Pharm Biopharm; 2008 Sep; 70(1):179-86. PubMed ID: 18667297
[TBL] [Abstract][Full Text] [Related]
13. Effect of menthol on ocular drug delivery.
Xu X; Yu N; Bai Z; Xun Y; Jin D; Li Z; Cui H
Graefes Arch Clin Exp Ophthalmol; 2011 Oct; 249(10):1503-10. PubMed ID: 21597947
[TBL] [Abstract][Full Text] [Related]
14. Diffusion of high molecular weight compounds through sclera.
Ambati J; Canakis CS; Miller JW; Gragoudas ES; Edwards A; Weissgold DJ; Kim I; Delori FC; Adamis AP
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1181-5. PubMed ID: 10752958
[TBL] [Abstract][Full Text] [Related]
15. Effect of eye pigmentation on transscleral drug delivery.
Cheruvu NP; Amrite AC; Kompella UB
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):333-41. PubMed ID: 18172110
[TBL] [Abstract][Full Text] [Related]
16. Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity.
Pitkänen L; Ranta VP; Moilanen H; Urtti A
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):641-6. PubMed ID: 15671294
[TBL] [Abstract][Full Text] [Related]
17. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling.
Ranta VP; Urtti A
Adv Drug Deliv Rev; 2006 Nov; 58(11):1164-81. PubMed ID: 17069929
[TBL] [Abstract][Full Text] [Related]
18. [Delivery of macromolecular drugs to the vitreous and its peripheral tissues].
Morita Y; Saino H; Tojo K
Nihon Rinsho; 1998 Mar; 56(3):628-31. PubMed ID: 9549347
[TBL] [Abstract][Full Text] [Related]
19. Ophthalmic preservatives as absorption promoters for ocular drug delivery.
Sasaki H; Nagano T; Yamamura K; Nishida K; Nakamura J
J Pharm Pharmacol; 1995 Sep; 47(9):703-7. PubMed ID: 8583378
[TBL] [Abstract][Full Text] [Related]
20. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide.
Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG
Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
